New Immunotherapy Treatment Darzalex for Multiple Myeloma Cancer1

http://youtu.be/Z7HfElR0ufw
Darzalex (daratumumab) is a recent FDA approved immunotherapy for the treatment of multiple myeloma cancer. In this video, Dr. Stephen Lemon, a medical oncologist, talks about how this immunotherapy treatment works, including what types of side effects it may cause. Visit https://www.lightersideofcancer.com/education/ to watch more new cancer treatments from Dr. Lemon.
Darzalex is developed by Janssen Biotech. Stephen Lemon MD is a medical oncologist who is not affiliated with Janssen Biotech.